LabCompass

Mollie E. Moran

Medicine · The Ohio State University

Established · publishing since 1977Rising activity

Publications

54

Citations

1,944

Est. group size

~13

Recurring co-author estimate

Active years

49

Publishing since 1977

Research summary
AI-generated

Mollie E. Moran's work focuses on chronic lymphocytic leukemia (CLL) and related blood cancers, particularly clinical trials testing new drug combinations (such as venetoclax, ibrutinib, acalabrutinib, and obinutuzumab) to improve treatment outcomes and address drug resistance. The research also covers practical aspects of patient care, including managing treatment side effects, infections, and autoimmune complications in CLL patients.

Chronic lymphocytic leukemia (CLL) treatmentClinical trials for blood cancer drug combinationsDrug resistance in leukemia therapyPatient safety and side-effect management in cancer treatmentAutoimmune and infectious complications in leukemia

Publication output has been steady but modest over the last decade, with a slight increase in recent years (2023-2025) after a gap in 2021.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.4/year recently
2017: 1 publication172018: 1 publication182019: 1 publication192020: 2 publications220212022: 1 publication222023: 2 publications2232024: 2 publications2242025: 2 publications22526
Publishes in
  • Blood×8
  • Blood Advances×2
  • Clinical journal of oncology nursing×1
  • Journal of the Advanced Practitioner in Oncology×1
  • Journal of Clinical Oncology×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile